By G HossainPosted on January 12, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs Hair loss–focused Veradermics and cancer biotech Eikon follow the lead of Aktis Oncology, which last week announced a $318 million IPO target. Veradermics, Eikon Eye Public Market Debut as IPO Tap Opens Post navigation Early-Stage Biotechs Feel the Squeeze as Funding Favors Derisked Assets: JPMStartup Aurora Seeks To Replicate Baby KJ Success With $16M in Seed Money